Loading content…
Affiliate-supportedIndependent editorialWe never sell medicationSee how
West · Washington
Local context for Wegovy, Ozempic, Mounjaro, and Zepbound in Seattle (750,000 residents, 4,000,000 metro). Apple Health (WA Medicaid) generally covers T2D GLP-1s with prior auth; UW Medicine anchors academic prescribing.
Availability and prices vary by pharmacy and date. We do not maintain real-time per-pharmacy stock data. Confirm with pharmacies directly.
Wegovy
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for chronic weight management in adults and adolescents.
Wegovy in Seattle →
Ozempic
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for adults with type 2 diabetes.
Ozempic in Seattle →
Mounjaro
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for adults with type 2 diabetes.
Mounjaro in Seattle →
Zepbound
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for chronic weight management and obstructive sleep apnea.
Zepbound in Seattle →
Seattle is a west-region city with a population of 750,000 (4,000,000 in the broader metropolitan area). Washington expanded Medicaid under the Affordable Care Act, which means low-income adults can typically qualify for GLP-1 coverage for type 2 diabetes if the state Medicaid program lists the drug.
Statewide, notable health systems include UW Medicine, Providence, Swedish Medical Center, Virginia Mason.
Washington's Medicaid program is Apple Health. Coverage rules for GLP-1 medications vary by drug and indication; see our pricing by state map and payer-coverage guides for details.
Cities of similar size with comparable healthcare markets.